Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Clinical trial NCT01950390 · COMPLETED
Trial details
- NCT number
- NCT01950390
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-24
- Primary completion
- 2021-10-06
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.